Skip links


Delivering on the Promise of Transformative Medicine for Diseases of the Central Nervous System

We combine a sophisticated understanding of human genetics and disease pathology with novel technology platforms to optimize the therapeutic potential of drug candidates.

We focus on targets with well-established human genetics and pharmacological evidence, while addressing the foundation biology to achieve the intended treatment benefit.

By applying genomics and breakthrough science, we select the suitable modality, identify the most promising molecules, and rapidly advance them to the clinic — at the right dose, to the right patients.

Investigational Therapies

Our investigational therapies target foundation biological processes, so we can explore their full therapeutic potential across a broad range of serious CNS indications.

Our discovery engine is powered by a set of interconnected and fit-for-purpose platform technologies that provide the ability to efficiently identify and evaluate novel drug candidates from less explored realms of chemistry and biology.

Our Pipeline